European shares rise 1% on tech boost; ECB meet in focus
For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window
ECB rate decision at 1215 GMT
Spain's inflation eased to 2.4% in August
ECB's Christine Lagarde remarks due at 1245 GMT
Updated at 0800 GMT
By Pranav Kashyap
Sept 12 (Reuters) -European shares climbed 1% on Thursday, buoyed by strong performances among technology stocks, while investors awaited a policy decision from the European Central Bank later in the day where a rate cut is almost a certainty.
The pan-European STOXX 600 index .STOXX was up 1% at 513.1 points, and set for the best day in more than one month, if gains hold.
All regional bourses were trading north of 1%.
Technology stocks .SX8P chimed with a rally in their Asian peers, and jumped 2.5% to provide the biggest boost to the European benchmark index.
A Semafor report said the U.S. government is considering letting Nvidia NVDA.O export advanced chips to Saudi Arabia, causing the AI-darling to surge 8%. .N
Basic resources .SXPP gained 2.3% after prices of base metals rose, buoyed by hopes of an interest rate reduction in the U.S. next week. MET/L.
All sub-sectors but one were trading in the green.
The European Central Bank (ECB) is set to convene at 1215 GMT, with widespread anticipation of a 25-basis-point rate reduction.
All eyes will be on ECB President Christine Lagarde's remarks, due at 1245 GMT, as markets eagerly await confirmation on whether additional rate cuts are on the horizon for October and December.
"A rate cut today is fully baked in. The focus of the market is going to be when is the next ECB rate cut? We're probably not going to get much guidance from that today," said Ben Laidler, head of equity strategy at Bradesco BBI.
"I don't think they need to do anything more aggressive. Clearly they could do though, if the data warranted it ... the ECB is going to go slow and steady."
Meanwhile, Spain's consumer price figures showed the 12-month EU-harmonised inflation eased to 2.4% in August, causing the benchmark IBEX 35 index .IBEX to gain more than 1%.
Swedish inflation eased 0.5% in August, just below forecast.
Shares of Roche ROG.S fell 4% after the Swiss drugmaker said promising results of an early-stage trial of its experimental weight-loss pill were based on just six patients.
An overnight reading of U.S. core CPI showed that it rose 0.28% in August, slightly above a forecast rise of 0.2%, and that was enough for skittish markets to finally decide that the Federal Reserve will settle for a 25 bps rate cut next week.
Reporting by Pranav Kashyap in Bengaluru; Editing by Sherry Jacob-Phillips
Mga Kaugnay na Asset
Pinakabagong Balita
Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.
Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.
Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.